Parkview Cancer Institute ( Site 0077) — Fort Wayne, Indiana

Parkview Cancer Institute ( Site 0077) is a clinical research site located in Fort Wayne, Indiana, United States 46845.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Parkview Cancer Institute ( Site 0077) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Urinary Bladder Cancer, Muscle-invasive, Bladder Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Parkview Cancer Institute ( Site 0077)?

Parkview Cancer Institute ( Site 0077) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Parkview Cancer Institute ( Site 0077) conducted?

Parkview Cancer Institute ( Site 0077) has 2 clinical trials on record, with 2 currently active. Their work covers Urinary Bladder Cancer, Muscle-invasive, Bladder Cancer.

Is Parkview Cancer Institute ( Site 0077) accredited by Crixeo Health?

Parkview Cancer Institute ( Site 0077) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Parkview Cancer Institute ( Site 0077)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.